Abraxane is a nanoparticle-albumin-bound formulation of the chemotherapeutic agent paclitaxel. It is used primarily in the treatment of metastatic breast cancer, non-small cell lung cancer, and pancreatic cancer. The drug leverages nanotechnology to improve the solubility and delivery of paclitaxel, making it more effective and reducing some of the side effects associated with traditional chemotherapy treatments.
